Drugs Used in Circadian Sleep-Wake Rhythm Disturbances.
Study Goal
The researchers aimed to review melatonin's circadian phase-shifting and sleep-enhancing properties, along with safety concerns and clinical guidelines for its use in circadian rhythm disorders.
Results Summary
The study found that melatonin and melatonin receptor agonists have significant circadian phase-shifting and sleep-enhancing effects, with practical treatment considerations discussed. Safety concerns were noted but not detailed.
Population
Individuals with intrinsic circadian rhythm sleep-wake disorders.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
melatonin | increase | circadian phase | - | - | circadian phase shifting | #1 |
melatonin | increase | sleep | - | - | sleep-enhancing | #2 |
other melatonin receptor agonists | increase | circadian phase | - | - | circadian phase shifting | #3 |
other melatonin receptor agonists | increase | sleep | - | - | sleep-enhancing | #4 |
This article focuses on melatonin and other melatonin receptor agonists, and specifically their circadian phase shifting and sleep-enhancing properties. The circadian system and circadian rhythm sleep-wake disorders are briefly reviewed, followed by a summary of the circadian phase shifting, sleep-enhancing properties, and possible safety concerns associated with melatonin and other melatonin receptor agonists. The recommended use of melatonin, including dose and timing, in the latest American Academy of Sleep Medicine Clinical Practice Guidelines for the treatment of intrinsic circadian rhythm disorders is also reviewed. Lastly, the practical aspects of treatment and consideration of clinical treatment outcomes are discussed.